J. Team Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$390K Sell
6,248
-46
-0.7% -$2.91K 0.34% 52
2026
Q2
$363K Buy
6,294
+64
+1% +$3.68K 0.35% 60
2026
Q1
$378K Sell
6,230
-833
-12% -$48.6K 0.42% 50
2025
Q4
$381K Sell
7,063
-615
-8% -$29.6K 0.38% 52
2025
Q3
$346K Buy
+7,678
New +$359K 0.35% 55

Other funds holding BMY

J. Team Financial's BMY Position: Q3 2026 in Review

J. Team Financial reduced its Bristol-Myers Squibb (BMY) stake by 0.73% in Q3 2026, selling an estimated $2.91K and leaving 6,248 shares worth $390K. The position accounts for 0.34% of the portfolio, ranked #52.

J. Team Financial first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • J. Team Financial held 6,248 shares of Bristol-Myers Squibb worth $390K as of Q3 2026.
  • J. Team Financial sold 46 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.91K.
  • Bristol-Myers Squibb made up 0.34% of J. Team Financial's portfolio in Q3 2026, its #52 holding.
  • J. Team Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on J. Team Financial's 13F filing for Q3 2026, filed 3 Nov 2026.